Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Neuroprotection in stroke. A critical overview].

F Block1, M Schwarz

  • 1Neurologische Klinik, RWTH, Aachen.

Der Nervenarzt
|March 31, 1999
PubMed
Summary

Neuroprotection strategies targeting excitotoxicity, free radicals, inflammation, and apoptosis show promise in experimental models of cerebral ischemia. However, clinical trials have yielded disappointing results due to study design differences.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

First Constraints on General Neutrino Interactions Based on KATRIN Data.

Physical review letters·2025
Same author

New Constraint on the Local Relic Neutrino Background Overdensity with the First KATRIN Data Runs.

Physical review letters·2022
Same author

Bound on 3+1 Active-Sterile Neutrino Mixing from the First Four-Week Science Run of KATRIN.

Physical review letters·2021
Same author

Improved Upper Limit on the Neutrino Mass from a Direct Kinematic Method by KATRIN.

Physical review letters·2019
Same author

The DeepTree Exhibit: Visualizing the Tree of Life to Facilitate Informal Learning.

IEEE transactions on visualization and computer graphics·2015
Same author

[Drug-induced seizures].

Fortschritte der Neurologie-Psychiatrie·2012

Area of Science:

  • Neuroscience
  • Pharmacology

Context:

  • Cerebral ischemia triggers complex pathophysiological cascades, including excitotoxicity, free radical formation, inflammation, and apoptosis, leading to neuronal damage.
  • Neuroprotection aims to mitigate these effects through pharmacological interventions.

Purpose:

  • To review the mechanisms of ischemic cell damage and the potential of neuroprotective agents.
  • To analyze the discrepancy between promising preclinical findings and failed clinical trials in neuroprotection.

Summary:

  • Experimental studies demonstrate that targeting excitotoxicity (glutamate antagonists), calcium overload (calcium antagonists), free radicals (radical scavengers), inflammation, and apoptosis can reduce ischemic brain damage.
  • Clinical trials have largely failed to show neuroprotective benefits, likely due to differences in study design, timing of intervention, and outcome measures.

Impact:

  • Highlights the need for improved preclinical study designs that better mimic clinical scenarios for developing effective neuroprotective therapies.
  • Suggests that future research should focus on optimizing the timing and evaluation methods for neuroprotective agents to improve clinical translation.

Related Experiment Videos